Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

  1. Filippi, A.R.
  2. Bar, J.
  3. Chouaid, C.
  4. Christoph, D.C.
  5. Field, J.K.
  6. Fietkau, R.
  7. Garassino, M.C.
  8. Garrido, P.
  9. Haakensen, V.D.
  10. Kao, S.
  11. Markman, B.
  12. McDonald, F.
  13. Mornex, F.
  14. Moskovitz, M.
  15. Peters, S.
  16. Sibille, A.
  17. Siva, S.
  18. van den Heuvel, M.
  19. Vercauter, P.
  20. Anand, S.
  21. Chander, P.
  22. Licour, M.
  23. de Lima, A.R.
  24. Qiao, Y.
  25. Girard, N.
Aldizkaria:
ESMO Open

ISSN: 2059-7029

Argitalpen urtea: 2024

Alea: 9

Zenbakia: 6

Mota: Artikulua

DOI: 10.1016/J.ESMOOP.2024.103464 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus